India, April 15 -- Obsessive-compulsive disorder (OCD) affects 1-3% of the global population, often beginning in childhood or adolescence. It traps people in cycles of intrusive thoughts and repetitive behaviors that can consume hours each day, disrupting work, relationships, and quality of life.
Despite being widely recognized, OCD remains underdiagnosed, with a shortage of trained specialists and high rates of treatment resistance.
A recent study published in Nature Mental Health highlights how researchers are re-thinking OCD care. Traditional first-in-line treatments- exposure and response prevention (ERP) therapy and selective serotonin reuptake inhibitors (SSRIs)- help many, but up to 60% of patients experience limited relief. For th...